AdventHealth's Dr. Vipul Patel Performs Telesurgery Across 35 Miles in Florida

Homi Bhabha Cancer Hospital & Research Centre in Visakhapatnam has performed its first robotic procedure and opened services to patients enrolled in Andhra Pradesh's NTR Vaidya Seva insurance scheme, with NTPC funding part of the build-out through its CSR programme. The detail that matters is the payer, not the platform: state-insured patients get access from day one. For robotics vendors, India's public-sector oncology centres are becoming a distinct and price-sensitive market tier.

A Small Wars Journal analysis documents how advances in AI, sensors, electronics, and navigation are driving military robotics toward ever smaller, lighter, and more autonomous platforms, from palm-sized quadcopters to insect-scale flyers. The shift rewrites cost and logistics math for defense buyers, favors suppliers of compact compute, batteries, and MEMS sensing, and pushes the hardest unsolved problems toward power, communications, and swarm coordination. For robotics engineers and investors, the miniaturization race is a components story first and a platforms story second.

SAiMON Robotics spent Ascend 2026 in Las Vegas evaluating dock-based and long-range autonomous aerial platforms that meet National Defense Authorization Act sourcing rules, with the goal of adding them to its Robots-as-a-Service catalog for public safety and security customers. The move shows how procurement compliance, not airframe performance, is increasingly deciding which drones reach police and security buyers. For RaaS operators, the real contest is over who can certify, integrate, and service compliant hardware fastest.

Fortescue is using modified KUKA automotive assembly-line robots, not humanoids, to connect 6 MW charging cables to its 240-tonne electric haul trucks in Western Australia's Pilbara region. The choice reflects a hard engineering reality: humanoid hardware cannot yet handle the cable weight, force, and environmental abuse of heavy-duty mining charging. For robotics vendors and investors, the deployment shows where proven industrial arms still beat the humanoid hype cycle, and where the real money in mining electrification may sit.

Noetix Robotics has filed confidentially for a Hong Kong initial public offering aimed at raising hundreds of millions of dollars, according to reports. The Chinese humanoid maker is betting that low-cost hardware, not feature-rich flagships, will define the next phase of the market. The listing would add another test of public-market appetite for humanoid robotics, a sector where valuations have run well ahead of shipment volumes. Investors will be watching unit economics closely.

Metropolis Robotics put its full-size SKYE humanoid on the floor of McCormick Place this week, staffing a booth for Adams Elevator at the NAEC 2026 trade show in Chicago. The Illinois company is using the vertical transportation industry's biggest gathering as a live test of whether humanoids can hold an audience in a commercial setting. For robotics executives, the real story is not the crowds. It is a new, low-risk sales channel for humanoid makers.

Intuitive Surgical beat Wall Street's third-quarter estimates, yet shares fell sharply Tuesday because management only narrowed its full-year 2026 procedure-growth outlook rather than raising it. Investors had priced in a bigger upgrade to da Vinci volume forecasts. The reaction shows how little room the robotic surgery leader has for anything short of acceleration. For a company valued on procedure growth, a tighter range reads as a ceiling, not a floor.

Gamma Robotics, the first market-oriented company incubated by China Telecom's TeleAI institute, has launched in Shanghai to build humanoid robots that improve themselves through operation rather than manual retraining. The company is also developing whole-body models for coordinated motion and manipulation. The spinout gives a state-owned telecom carrier its first direct stake in commercial embodied AI, and it tests whether network operators can compete with dedicated robotics startups on software-defined machines.

maxon UK & Ireland's medical chief Matthew Dean argues that force feedback, not raw actuator power, is now the deciding factor in surgical robot control. The case rests on coreless brushless DC motors, whose low inertia and clean current-to-torque behavior let designers sense tissue contact through the motor itself. For OEMs, that points toward fewer dedicated force sensors, smaller instrument tips and tighter sterilization constraints. Surgeons stand to regain the sense of touch that minimally invasive procedures took away.

Defense Secretary Pete Hegseth is asking Congress for $50 billion in reconciliation funding to scale autonomous and robotic systems, a sum that would dwarf prior drone line items and reshape procurement for the entire unmanned sector. The request pushes the Pentagon toward volume manufacturing over bespoke acquisition. For suppliers, the money signals demand for components, autonomy software, and factory automation. The open question is whether production capacity exists to absorb it.

A KRW2.2 trillion (about US$1.66 billion) private investment plan names 12 companies, many of them automotive and machinery component makers, to build a domestic humanoid robot supply chain in Daegu. The city is trying to convert a legacy auto-parts base into a humanoid manufacturing cluster rather than ceding actuators, reducers, and structural components to Chinese suppliers. The plan's real test is whether mid-tier parts makers can hit humanoid-grade precision at volume pricing.

NVIDIA has released Cosmos3-H-Dreams, a real-time, action-conditioned generative world model fine-tuned on clinical cholecystectomy recordings from CMR Surgical's Versius system. The checkpoint and companion code went public on October 20, 2026. NVIDIA says it is the first real-time generative surgical simulator trained on clinical gallbladder-removal footage. For surgical robotics developers, the open release could lower the cost of testing autonomy software without operating rooms, though clinical validity remains unproven.